Cargando…

Prices of oncology medicines in European countries, Australia and New Zealand

Detalles Bibliográficos
Autores principales:	Vogler, Sabine, Vitry, Agnes, Ud-Bin-Babar, Zaheer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603627/ http://dx.doi.org/10.1186/2052-3211-8-S1-P16

Ejemplares similares

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region
por: Nguyen, Tuan A, et al.
Publicado: (2015)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012)

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021)

Reimbursement measures in European countries – findings of a bibliometric literature review
por: Vogler, Sabine, et al.
Publicado: (2015)

Policy options to deal with high-cost medicines – survey with European policy-makers
por: Zimmermann, Nina, et al.
Publicado: (2015)

Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
por: Vogler, Sabine, et al.
Publicado: (2019)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Design of value-added tax on medicines in 41 European countries
por: Vogler, S, et al.
Publicado: (2022)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

The outcome of sepsis and septic shock presenting to the Emergency Department in Australia and New Zealand
por: Peake, S, et al.
Publicado: (2007)

The Anorexia Nervosa: Genetics Initiative (ANGI): Australia and New Zealand join forces
por: Kennedy, Martin, et al.
Publicado: (2015)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial
por: Gormly, KLM, et al.
Publicado: (2015)

A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023)

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

P05.28. Current practice amongst acupuncturists treating threatened miscarriage in Australia and New Zealand
por: Betts, D, et al.
Publicado: (2012)

New Zealand’s Drug Development Industry
por: Lockhart, Michelle Marie, et al.
Publicado: (2013)

Temperature management for patients without brain injury in Australia and New Zealand ICUs: a point prevalence study
por: Hammond, NE, et al.
Publicado: (2012)

“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries
por: Vogler, Sabine
Publicado: (2022)

The prices outpatients have to pay for purchasing medicines in Armenia
por: Kazaryan, Irina, et al.
Publicado: (2015)

Optimising prescribing in primary care: an evaluation of financial and clinical parameters
por: Albayati, Asal, et al.
Publicado: (2015)

Assessment of the therapeutic value of new medicines marketed in Australia
por: Vitry, Agnes I, et al.
Publicado: (2013)

Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
por: Vitry, Agnes I
Publicado: (2013)

P137 Diagnosis of nocturnal hypoventilation in children with neuromuscular disorders by polysomnography – a survey of clinical practice in Australia and New Zealand
por: Withers, A, et al.
Publicado: (2022)

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
por: Iyengar, Swathi, et al.
Publicado: (2016)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation
por: Vogler, Sabine, et al.
Publicado: (2020)

Comparison of Cardiovascular Medicines Prices in Four European Countries
por: Mitkova, Zornitsa, et al.
Publicado: (2020)

“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
por: Vitry, Agnes, et al.
Publicado: (2021)

Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study
por: Yang, Caijun, et al.
Publicado: (2020)

Determining the prices of the medicines in the absence of superiority over alternative medical technology
por: Matusewicz, Wojciech, et al.
Publicado: (2015)

Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries
por: Vogler, Sabine, et al.
Publicado: (2022)

Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
por: Moye-Holz, Daniela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7de83jnsrcv68jmga6k9euubv